Zynex Inc is a medical technology company that specializes in the development and manufacturing of non-invasive medical devices, primarily focused on pain management and rehabilitation
The company's innovative products include electrotherapy devices that utilize neuromuscular electrical stimulation to help patients manage acute and chronic pain, as well as devices designed to aid in physical therapy and recovery. Zynex is committed to improving patient outcomes through its advanced technology and is actively involved in expanding its offerings to meet the growing needs of the healthcare market.
Zynex Inc's (NASDAQZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than November 1, 2024, or when the $20.0 million limit is reached.
